ProfileGDS4718 / 201283_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 43% 25% 44% 41% 27% 20% 38% 47% 42% 35% 29% 37% 30% 22% 37% 41% 36% 24% 35% 38% 42% 41% 44% 33% 28% 41% 28% 46% 23% 34% 29% 40% 45% 18% 24% 37% 40% 42% 20% 34% 36% 25% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7982536
GSM549102patient 115, normal, homogenized [OPG study]5.1453443
GSM549104patient 119, normal, homogenized [OPG study]4.314625
GSM549108patient 138, normal, homogenized [OPG study]5.2408944
GSM549119patient 077, normal, homogenized [OPG study]5.0558941
GSM549133patient 032, cancer, homogenized [OPG study]4.3654327
GSM549139patient 042, cancer, homogenized [OPG study]4.1425820
GSM549099patient 107, normal, homogenized [OPG study]4.941138
GSM549109patient 139, normal, homogenized [OPG study]5.3479547
GSM549110patient 046, normal, homogenized [OPG study]5.0979742
GSM549114patient 063, normal, homogenized [OPG study]4.6983235
GSM549122patient 082, normal, homogenized [OPG study]4.5231729
GSM549134patient 033, cancer, homogenized [OPG study]4.8630137
GSM549136patient 036, cancer, homogenized [OPG study]4.4655230
GSM549140patient 044, cancer, homogenized [OPG study]4.1684622
GSM549111patient 047, normal, homogenized [OPG study]4.7985737
GSM549113patient 057, normal, homogenized [OPG study]4.9801441
GSM549132patient 031, cancer, homogenized [OPG study]4.7872636
GSM549137patient 038, cancer, homogenized [OPG study]4.2690424
GSM549142patient 047, cancer, homogenized [OPG study]4.8644535
GSM549100patient 110, normal, homogenized [OPG study]4.914338
GSM549107patient 135, normal, homogenized [OPG study]5.0707542
GSM549115patient 068, normal, homogenized [OPG study]4.9680741
GSM549116patient 072, normal, homogenized [OPG study]5.1604944
GSM549120patient 078, normal, homogenized [OPG study]4.6732333
GSM549131patient 030, cancer, homogenized [OPG study]4.4209428
GSM549118patient 074, normal, homogenized [OPG study]5.0190241
GSM549129patient 027, cancer, homogenized [OPG study]4.490228
GSM549123patient 088, normal, homogenized [OPG study]5.261646
GSM549124patient 006, cancer, homogenized [OPG study]4.3127423
GSM549126patient 015, cancer, homogenized [OPG study]4.6922134
GSM549128patient 025, cancer, homogenized [OPG study]4.4662929
GSM549103patient 117, normal, homogenized [OPG study]5.0393740
GSM549117patient 073, normal, homogenized [OPG study]5.2098845
GSM549138patient 041, cancer, homogenized [OPG study]4.04318
GSM549141patient 045, cancer, homogenized [OPG study]4.247724
GSM549130patient 028, cancer, homogenized [OPG study]4.8664437
GSM549101patient 111, normal, homogenized [OPG study]5.0142240
GSM549105patient 128, normal, homogenized [OPG study]5.1115642
GSM549106patient 134, normal, homogenized [OPG study]4.089420
GSM549112patient 048, normal, homogenized [OPG study]4.7164534
GSM549125patient 011, cancer, homogenized [OPG study]4.7982536
GSM549127patient 024, cancer, homogenized [OPG study]4.3077325
GSM549135patient 035, cancer, homogenized [OPG study]4.5016530